Eisai Co Ltd
TSE:4523

Watchlist Manager
Eisai Co Ltd Logo
Eisai Co Ltd
TSE:4523
Watchlist
Price: 4 515 JPY -1.87% Market Closed
Market Cap: 1.3T JPY

Relative Value

The Relative Value of one Eisai Co Ltd stock under the Base Case scenario is 6 543.99 JPY. Compared to the current market price of 4 515 JPY, Eisai Co Ltd is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 543.99 JPY
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
60
Median 3Y
2.4
Median 5Y
2.6
Industry
2.7
Forward
1.6
vs History
77
vs Industry
23
Median 3Y
41
Median 5Y
39.3
Industry
21.4
Forward
25.7
vs History
66
vs Industry
7
Median 3Y
38.9
Median 5Y
32.1
Industry
16.8
vs History
82
vs Industry
17
Median 3Y
33.7
Median 5Y
32.7
Industry
23.1
vs History
84
vs Industry
51
Median 3Y
2
Median 5Y
2.2
Industry
2.3
vs History
84
vs Industry
65
Median 3Y
2.2
Median 5Y
2.4
Industry
2.9
Forward
1.4
vs History
84
vs Industry
75
Median 3Y
2.7
Median 5Y
3
Industry
5.5
vs History
87
vs Industry
35
Median 3Y
17.8
Median 5Y
18.2
Industry
13.3
Forward
11.2
vs History
71
vs Industry
29
Median 3Y
24.8
Median 5Y
25.4
Industry
16.5
Forward
15.5
vs History
66
vs Industry
8
Median 3Y
34.9
Median 5Y
28.6
Industry
16
vs History
52
vs Industry
1
Median 3Y
54.8
Median 5Y
45.7
Industry
18.9
vs History
84
vs Industry
59
Median 3Y
1.5
Median 5Y
1.7
Industry
2

Multiples Across Competitors

Competitors Multiples
Eisai Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Eisai Co Ltd
TSE:4523
1.3T JPY 1.6 25.8 11 18.1
US
Eli Lilly and Co
NYSE:LLY
982.2B USD 16.5 53.3 35.8 38.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
526.1B USD 5.7 20.9 17.1 22.2
CH
Roche Holding AG
SIX:ROG
277.8B CHF 4.5 29.5 12.5 14.6
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP 5 31 108.8 159.2
CH
Novartis AG
SIX:NOVN
221.8B CHF 4.9 19.2 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
270.7B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.5 16.6 11.6 13.4
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
145.8B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
JP
Eisai Co Ltd
TSE:4523
Average P/E: 25.1
25.8
14%
1.8
US
Eli Lilly and Co
NYSE:LLY
53.3
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
37%
0.8
CH
Novartis AG
SIX:NOVN
19.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
16.6
3%
5.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Eisai Co Ltd
TSE:4523
Average EV/EBITDA: 401
11
12%
0.9
US
Eli Lilly and Co
NYSE:LLY
35.8
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.1
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
12.1
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.6
1%
11.6
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Eisai Co Ltd
TSE:4523
Average EV/EBIT: 1 714.1
18.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.4
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.2
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.6
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
CH
Novartis AG
SIX:NOVN
15.7
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5